NCT05798169

Brief Summary

Sarcopenia characterised by loss of muscle mass, muscle strength and physical performance burdens many older adults since the condition is related to functional decline. Periods of inactivity such as during hospitalisation leads to further functional decline. It has been reported that the loss of muscle mass associated with sarcopenia not only entails a decrease in muscle mass but also changes in muscle architecture. Knowledge on changes in muscle architecture is essential since it is one of the most important determinants on muscle strength and thus physical performance. The main objective of this study is to investigate changes in muscle architecture and physical performance during acute hospitalisation and after discharge in older adults and subsequently the effectiveness of resistance training of the lower limb during acute hospitalisation. If successful, our study could have a great impact on the individual, as well as societal level, due to a better understanding of the factors related to sarcopenia and the prevention of functional decline as a result of hospitalisation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
274

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

January 5, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 4, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2024

Completed
Last Updated

March 27, 2025

Status Verified

March 1, 2025

Enrollment Period

2 years

First QC Date

November 7, 2022

Last Update Submit

March 24, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change from baseline B-mode ultrasonography

    Muscle architecture of the m Vastus Lateralis assessed with B-mode ultrasonography.

    Baseline (day of hospitalisation) to day of discharge from hospital (an average of a week).

  • Change from baseline 4 meter Gait Speed Test

    Physical performance evaluated by the 4m Gait Speed test

    Baseline (Day of hospitalisation) to day of discharge from hospital (an average of a week).

  • Change from baseline B-mode ultrasonography

    Muscle architecture of the muscle vastus lateralis assessed with B-mode ultrasonography.

    Change from baseline (day of hospitalisation) to 1-month follow-up and 3-months follow-up

  • Change from baseline 4 meter Gait Speed Test

    Physical performance evaluated by the 4m Gait Speed test

    Change from baseline (day of hospitalisation) to 1-month follow-up and 3-months follow-up

Secondary Outcomes (7)

  • Change from baseline 30s Chair Stand test

    Baseline (day of hospitalisation) to day of discharge from hospital (an average of a week)

  • Change from baseline Barthel-Index 100 (Shahs version)

    Baseline (day of hospitalisation) to day of discharge from hospital (an average of a week)

  • Change from baseline Bioimpedance

    Baseline (day of hospitalisation) to day of discharge from hospital (an average of a week)

  • Length of hospital stay

    Baseline (day of hospitalisation) to day of discharge from hospital (an average of a week)

  • Mortality

    Baseline (day of hospitalization) to 3-months follow-up

  • +2 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Group of participants receiving resistance training during hospitalisation

Other: Resistance training

Control Group

SHAM COMPARATOR

Group of participants receiving sham training during hospitalisation

Other: Resistance training

Interventions

Moderate resistance training by a innovative training robot 2 times a day during hospitalisation

Control GroupIntervention Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • ≥65 years of age
  • Able to ambulate before hospitalization (with/without assistance)
  • Able to communicate with the research team
  • Expected length of stay ≥2 days
  • Residing on Funen

You may not qualify if:

  • Able to ambulate without assistance during current hospitalization
  • Known severe dementia
  • Positive Confusion and Assessment Method score
  • Patients who have received less than 3 resistance training sessions at discharge
  • Terminal illness
  • Recent major surgery or lower extremity bone fracture in the last 3 months
  • Conditions contradicting use of ROBERT(unstable vertebral-, pelvic, or lower extremity fractures
  • high intracranial pressure
  • pressure ulcers or risk of developing pressure ulcers due to fragile skin
  • patients with medical instability)
  • Metastases at femur hip
  • Deemed not suitable for resistance training sessions with the robot by the healthcare professional.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geriatric Deparment OUH Svendborg Hospital

Svendborg, FYN, 5700, Denmark

Location

MeSH Terms

Conditions

Sarcopenia

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Kristian B Buhl, MD

    Department of Geriatric, Odense University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 7, 2022

First Posted

April 4, 2023

Study Start

January 5, 2023

Primary Completion

December 20, 2024

Study Completion

December 20, 2024

Last Updated

March 27, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

No plan

Locations